HealthStream (NASDAQ:HSTM) EVP Michael Manning Collier Sells 21,300 Shares of Stock

HealthStream, Inc. (NASDAQ:HSTM) EVP Michael Manning Collier sold 21,300 shares of the company’s stock in a transaction dated Thursday, November 5th. The stock was sold at an average price of $29.97, for a total value of $638,361.00. Following the transaction, the executive vice president directly owned 59,260 shares of the company’s stock, valued at approximately $1,776,022.20. This represents a 26.44% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link.

HealthStream Price Performance

NASDAQ HSTM opened at $28.89 on Friday. The company’s fifty day moving average price is $31.20 and its two-hundred day moving average price is $25.83. The company has a market capitalization of $844.17 million, a price-to-earnings ratio of 41.27, a price-to-earnings-growth ratio of 4.00 and a beta of 0.45. HealthStream, Inc. has a 12 month low of $19.50 and a 12 month high of $35.60.

HealthStream (NASDAQ:HSTM) last announced its quarterly earnings data on Monday, November 2nd. The technology company reported $0.18 EPS for the quarter, beating analysts’ consensus estimates of $0.16 by $0.02. The business had revenue of $83.31 million during the quarter, compared to analyst estimates of $82.24 million. HealthStream had a net margin of 6.25% and a return on equity of 6.58%. As a group, analysts anticipate that HealthStream, Inc. will post 0.80 EPS for the current year.

HealthStream Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, November 27th. Shareholders of record on Monday, November 16th will be given a dividend of $0.0350 per share. This represents a $0.14 annualized dividend and a yield of 0.5%. The ex-dividend date of this dividend is Monday, November 16th. HealthStream’s payout ratio is currently 20.00%.

Wall Street Analysts Forecast Growth

Several analysts have commented on HSTM shares. Citigroup reaffirmed a “market perform” rating on shares of HealthStream in a research note on Tuesday, October 27th. Wall Street Zen raised shares of HealthStream from a “hold” rating to a “buy” rating in a research note on Saturday, October 31st. Canaccord Genuity Group increased their target price on HealthStream from $29.00 to $32.00 and gave the company a “hold” rating in a research note on Wednesday. Weiss Ratings raised HealthStream from a “hold (c+)” rating to a “buy (b-)” rating in a report on Thursday, October 8th. Finally, Freedom Capital upgraded HealthStream to a “hold” rating in a report on Tuesday, October 13th. One research analyst has rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $36.00.

Hedge Funds Weigh In On HealthStream

Hedge funds have recently made changes to their positions in the business. BlackRock Inc. purchased a new stake in HealthStream in the second quarter valued at about $111,184,000. Dimensional Fund Advisors LP grew its position in shares of HealthStream by 6.4% in the first quarter. Dimensional Fund Advisors LP now owns 1,456,043 shares of the technology company’s stock valued at $30,156,000 after purchasing an additional 87,177 shares during the period. Copeland Capital Management LLC grew its stake in HealthStream by 43.8% during the 1st quarter. Copeland Capital Management LLC now owns 1,276,739 shares of the technology company’s stock valued at $26,441,000 after purchasing an additional 389,186 shares in the last quarter. Renaissance Technologies LLC boosted its holdings in shares of HealthStream by 0.5% in the first quarter. Renaissance Technologies LLC now owns 477,848 shares of the technology company’s stock valued at $9,896,000 after acquiring an additional 2,380 shares in the last quarter. Finally, Arrowstreet Capital Limited Partnership increased its stake in shares of HealthStream by 21.1% in the first quarter. Arrowstreet Capital Limited Partnership now owns 377,945 shares of the technology company’s stock worth $7,827,000 after acquiring an additional 65,806 shares during the last quarter. Institutional investors own 69.58% of the company’s stock.

Key HealthStream News

Here are the key news stories impacting HealthStream this week:

• Positive Sentiment: Buy rating upgrade: Zacks upgraded HSTM to Rank #2 (Buy), citing improving earnings prospects, which could support investor optimism. Zacks article
• Positive Sentiment: Raised guidance: HealthStream lifted its outlook, a potentially positive sign for expected business performance, although the article raises the question of whether prior gains already reflect the news. Yahoo Finance article
• Neutral Sentiment: Analyst views remain cautious: Canaccord Genuity raised its price target to $32 from $29 but maintained a Hold rating; Craig Hallum also moved its rating to Hold. These calls suggest limited conviction despite the higher target. Canaccord rating information Craig Hallum rating article
• Negative Sentiment: Multiple insider sales: On November 5, EVP Michael Manning Collier, CFO Scott Alexander Roberts, Director Deborah Tate and EVP Kevin O’Hara sold a combined 38,081 shares. Each reduced their individual holdings, a cluster of transactions that may weigh on sentiment, though insider sales alone do not establish a change in the company’s outlook. Collier SEC filing Roberts SEC filing Tate SEC filing O’Hara SEC filing

About HealthStream

HealthStream, Inc provides workforce and provider solutions designed for healthcare organizations. Its software and services help hospitals, health systems, medical practices and other healthcare providers manage employee education, training, credentialing, compliance and professional development.

The company’s offerings include learning management and education tools, competency and performance-management solutions, and systems for managing provider credentials, privileging and enrollment.